The analyses showed that there were significant differences in CYTOR, HAR1A and MIAT expression levels among the four subtypes of GBM in TCGA (P =0.003, P =0.004 and P =0.001, respectively; Figure 3). The gene discussed is MIAT; the disease is glioblastoma.